chr2-85327226-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006464.4(TGOLN2):c.506G>T(p.Gly169Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,612,672 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGOLN2 | NM_006464.4 | c.506G>T | p.Gly169Val | missense_variant | 2/4 | ENST00000377386.8 | NP_006455.2 | |
TGOLN2 | NM_001368095.1 | c.506G>T | p.Gly169Val | missense_variant | 2/4 | NP_001355024.1 | ||
TGOLN2 | NM_001368096.1 | c.506G>T | p.Gly169Val | missense_variant | 2/4 | NP_001355025.1 | ||
TGOLN2 | NM_001206844.2 | c.506G>T | p.Gly169Val | missense_variant | 2/5 | NP_001193773.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGOLN2 | ENST00000377386.8 | c.506G>T | p.Gly169Val | missense_variant | 2/4 | 1 | NM_006464.4 | ENSP00000366603 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000106 AC: 16AN: 151000Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000237 AC: 59AN: 249262Hom.: 0 AF XY: 0.000244 AC XY: 33AN XY: 135216
GnomAD4 exome AF: 0.000118 AC: 173AN: 1461672Hom.: 1 Cov.: 37 AF XY: 0.000121 AC XY: 88AN XY: 727118
GnomAD4 genome AF: 0.000106 AC: 16AN: 151000Hom.: 0 Cov.: 33 AF XY: 0.000122 AC XY: 9AN XY: 73690
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2023 | The c.506G>T (p.G169V) alteration is located in exon 2 (coding exon 2) of the TGOLN2 gene. This alteration results from a G to T substitution at nucleotide position 506, causing the glycine (G) at amino acid position 169 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at